127 related articles for article (PubMed ID: 16498771)
1. Evaluation of new gastro-intestinal prokinetic (ENGIP-I) study.
Walwaikar PP; Kulkarni SS; Bargaje RS
J Indian Med Assoc; 2005 Oct; 103(10):559-60. PubMed ID: 16498771
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of new gastro-intestinal prokinetic (ENGIP-II) study.
Walwaikar PP; Kulkarni SS; Bargaje RS
J Indian Med Assoc; 2005 Dec; 103(12):708-9. PubMed ID: 16821670
[TBL] [Abstract][Full Text] [Related]
3. The effects of itopride on oesophageal motility and lower oesophageal sphincter function in man.
Scarpellini E; Vos R; Blondeau K; Boecxstaens V; Farré R; Gasbarrini A; Tack J
Aliment Pharmacol Ther; 2011 Jan; 33(1):99-105. PubMed ID: 21083582
[TBL] [Abstract][Full Text] [Related]
4. Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials.
Talley NJ; Tack J; Ptak T; Gupta R; Giguère M
Gut; 2008 Jun; 57(6):740-6. PubMed ID: 17965059
[TBL] [Abstract][Full Text] [Related]
5. Long-term gastroesophageal reflux disease therapy improves reflux symptoms in elderly patients: five-year prospective study in community medicine.
Miyamoto M; Haruma K; Kuwabara M; Nagano M; Okamoto T; Tanaka M
J Gastroenterol Hepatol; 2007 May; 22(5):639-44. PubMed ID: 17444849
[TBL] [Abstract][Full Text] [Related]
6. Treatment of patients with heartburn without endoscopic evaluation: on-demand treatment after effective continuous administration of lansoprazole 15 mg.
Bigard MA; Genestin E
Aliment Pharmacol Ther; 2005 Oct; 22(7):635-43. PubMed ID: 16181303
[TBL] [Abstract][Full Text] [Related]
7. Randomised, double-blind, comparative study to evaluate the efficacy and safety of ganaton (itopride hydrochloride) and mosapride citrate in the management of functional dyspepsia.
Amarapurkar DN; Rane P
J Indian Med Assoc; 2004 Dec; 102(12):735-7, 760. PubMed ID: 15871365
[TBL] [Abstract][Full Text] [Related]
8. Effect of itopride, a new prokinetic, in patients with mild GERD: a pilot study.
Kim YS; Kim TH; Choi CS; Shon YW; Kim SW; Seo GS; Nah YH; Choi MG; Choi SC
World J Gastroenterol; 2005 Jul; 11(27):4210-4. PubMed ID: 16015691
[TBL] [Abstract][Full Text] [Related]
9. Determinants of gastro-oesophageal reflux perception in patients with persistent symptoms despite proton pump inhibitors.
Zerbib F; Duriez A; Roman S; Capdepont M; Mion F
Gut; 2008 Feb; 57(2):156-60. PubMed ID: 17951358
[TBL] [Abstract][Full Text] [Related]
10. Rabeto plus: a valuable drug for managing functional dyspepsia.
Ghosh A; Halder S; Mandal S; Mandal A; Basu M; Dabholkar P
J Indian Med Assoc; 2008 Nov; 106(11):752-4. PubMed ID: 19368103
[TBL] [Abstract][Full Text] [Related]
11. Relationship between acceleration of gastric emptying and oesophageal acid exposure in patients with endoscopy-negative gastro-oesophageal reflux disease.
Carmagnola S; Fraquelli M; Cantù P; Conte D; Penagini R
Scand J Gastroenterol; 2006 Jul; 41(7):767-72. PubMed ID: 16785188
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of itopride hydrochloride in patients with non-ulcer dyspepsia.
Shenoy KT; Veenasree ; Leena KB
J Indian Med Assoc; 2003 Jun; 101(6):387-8. PubMed ID: 14579989
[TBL] [Abstract][Full Text] [Related]
13. Effect of itopride on gastric emptying in longstanding diabetes mellitus.
Stevens JE; Russo A; Maddox AF; Rayner CK; Phillips L; Talley NJ; Giguère M; Horowitz M; Jones KL
Neurogastroenterol Motil; 2008 May; 20(5):456-63. PubMed ID: 18179609
[TBL] [Abstract][Full Text] [Related]
14. Heartburn during sleep: a clinical marker of gastro-oesophageal reflux disease in morbidly obese patients.
Fornari F; Madalosso CA; Callegari-Jacques SM; Gurski RR
Neurogastroenterol Motil; 2009 Feb; 21(2):136-42. PubMed ID: 18651868
[TBL] [Abstract][Full Text] [Related]
15. Association of body mass index with heartburn, regurgitation and esophagitis: results of the Progression of Gastroesophageal Reflux Disease study.
Nocon M; Labenz J; Jaspersen D; Meyer-Sabellek W; Stolte M; Lind T; Malfertheiner P; Willich SN
J Gastroenterol Hepatol; 2007 Nov; 22(11):1728-31. PubMed ID: 17914941
[TBL] [Abstract][Full Text] [Related]
16. Pathophysiological characteristics of the various forms of gastro-oesophageal reflux disease. Spectrum disease or distinct phenotypic presentations?
Frazzoni M; Manno M; De Micheli E; Savarino V
Dig Liver Dis; 2006 Sep; 38(9):643-8. PubMed ID: 16627016
[TBL] [Abstract][Full Text] [Related]
17. Effect of cisapride on gastric emptying in patients with gastro-oesophageal reflux disease.
Koruk M; Yildirim M; Onuk MD; Varoğlu E
J Int Med Res; 2001; 29(5):389-91. PubMed ID: 11725825
[TBL] [Abstract][Full Text] [Related]
18. Gastro-oesophageal reflux disease and irritable bowel syndrome: a significant association in an Iranian population.
Solhpour A; Pourhoseingholi MA; Soltani F; Zarghi A; Solhpour A; Habibi M; Zali MR
Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):719-25. PubMed ID: 18617775
[TBL] [Abstract][Full Text] [Related]
19. Effects of itopride hydrochloride and ranitidine in patients with functional dyspepsia: comparison between prokinetic and acid suppression therapies.
Chiba T; Tokunaga Y; Ikeda K; Takagi R; Chishima R; Terui T; Kudara N; Endo M; Inomata M; Orii S; Suzuki K
Hepatogastroenterology; 2007 Sep; 54(78):1878-81. PubMed ID: 18019739
[TBL] [Abstract][Full Text] [Related]
20. Otolaryngologic manifestations of gastro-oesophageal reflux disease in Lagos.
Somefun OA; Wanda CB; Adesanya AA; Thomas MO; Esan OO
Niger Postgrad Med J; 2006 Sep; 13(3):225-9. PubMed ID: 17066111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
